(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.
The FDA is attempting to rehire some of the 300 employees it recently dismissed, including scientists responsible for ...
Boston Scientific (NYSE: BSX) announced that its Europe-based subsidiary priced a public offering totaling $1.57 billion ...
Fresenius Medical Care announced today that it agreed to sell select assets of its laboratory testing services to Quest Diagnostics.
OrganOx announced today that it completed a $142 million primary and secondary equity financing to accelerate growth opportunities.
Philips (NYSE: PHG) issued an urgent field safety notice to warn of a potential safety issue with its IntelliSpace Cardiovascular system.
Neurovalens said its Modius Sleep insomnia treatment will be available to veterans through a U.S. Department of Veterans Affairs program.